Phase II study of daily administration of TS-1 plus lentinan (LNT) in advanced or recurrent gastric cancer.
Phase of Trial: Phase II
Latest Information Update: 09 Sep 2013
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Lentinan (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 07 Aug 2012 New trial record